Al-Tel received his MS in Natural Product Chemistry in 1990 from the Department of Chemistry, Jordan University, and Pennsylvania State University, and PhD in 1995 from Tuebingen University-Germany followed by an NIH Postdoctoral Fellowship under the supervision of Professor Scott Sieburth, at the State University of New York, Stony Brook, NY. In 2003 he was appointed as a visiting associate professor at Duke Chemistry Department, North Carolina. Al-Tel joined Transtech Pharma-USA, a Drug Discovery and Development Company from 2004 to 2007 as a principal scientist and promoted to a Team Leader for Drug discovery groups (antiviral, anticancer, and Alzheimers). In 2007, he joined the college of pharmacy-University of Sharjah in the United Arab Emirates. Scientific Contribution includes over 80 publications in leading journals; inventor on five US-patents and patent applications. Research Interests: The research of AlTel is at the interface between biology and chemistry. AlTel focus area is drug design and discovery employing DOS for the synthesis of nature-inspired architectures. Major Awards include: The German Award for the Exchange of Scholars (DAAD); Abdel Hameed Shoman Prize for Young Arab Researchers (1999); Fulbright Award (2003/2004); The Chemist of the Year Award-2005, TransTech Pharma-USA. Scientific and Professional Activities include American Chemical Society-member and co-chair of the American Chemical Society-UAE-Chapter. Academic Appointments: Professor of Organic Medicinal Chemistry at the University of Sharjah. Chaired the Department of Medicinal Chemistry at the College of Pharmacy, the University of Sharjah from 2009 to 20015. Current position: Director of the Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE (2014 to present).
Medicinal Chemistry
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
